CaHMB(Calcium β-Hydroxy-β-methylbutyrate)

MFDS recognition no.	2023-26
Approval route	Notified (고시형) — listed in MFDS public standards
Daily intake (as approved)	3.0–3.0 g/일
Approval holder	㈜주피터인터내셔널

Approved wording (Korean original)

운동수행능력 향상에 도움을 줄 수 있음

Precautions (Korean original)

① 영·유아, 어린이, 임산부 및 수유부는 섭취 시 주의바랍니다.② 특정 질환(알레르기 체질 등)이 있는 분은 섭취 시 주의바랍니다.③ 이상사례 발생 시 섭취를 중단하고 전문가와 상담하시기 바랍니다.

the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.

Sourcing from Korea

Last synchronised: 2026-07-22

Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.